Enabling the Virtual Human Through Physiologically-based Pharmacokinetic Modeling

Publication
Article
BioPharm InternationalBioPharm International-03-15-2021
Volume 2021 eBook
Issue 1
Pages: 27–30

Basic principles of physiologically-based pharmacokinetic (PBPK) modeling and its impact in streamlining the drug development process are reviewed.

Predictive sciences—built on improved computational capabilities and a deeper understanding of human physiology—are allowing researchers to perform human studies prior to, and sometimes in place of, human clinical trials in order to predict drug outcomes. Representatives of the Translational & ADME Sciences Leadership Group (TALG) in the IQ Consortium review the basic principles of physiologically-based pharmacokinetic (PBPK) modeling and its impact in streamlining the drug development process.

Read this article in BioPharm International's Regulatory Sourcebook March 2021 eBook.

Article Details

BioPharm International
eBook: Regulatory Sourcebook
March 2021
Pages: 27–30

Citation

When referring to this article, please cite it as H. Einolf, et al., " Enabling the Virtual Human Through Physiologically-based Pharmacokinetic Modeling," BioPharm International Regulatory Sourcebook eBook (March 2021).

Articles in this issue
PAULISTA - STOCK.ADOBE.COM
It Takes a Bio/Pharma Village
PAULISTA - STOCK.ADOBE.COM
Enabling the Virtual Human Through Physiologically-based Pharmacokinetic Modeling
scientist with test tube and dna helix
Overcoming Challenges to Biopharmaceutical Development and Manufacture with Science- and Risk-Based Strategies
PAULISTA - STOCK.ADOBE.COM
Extrapolating Data from Adult Clinical Trials to Advance Pediatric Drug Development
PAULISTA - STOCK.ADOBE.COM
Collaborative Efforts Address Key Data Integrity Challenges
Can FDA Reinvent Inspections?
Can FDA Reinvent Inspections?
scientists doing drug development or drug testing work in lab
Growing Pipeline of Antisense Oligonucleotides Prompts Guidance
dna helixes being engineered, image represents gene therapies being developed
Gene Therapies Target Neurodegenerative Diseases
A Real-World Approach to Evaluating Cleanroom Garments
A Real-World Approach to Evaluating Cleanroom Garments
thodonal - Stock.adobe.com
FDA 2021 Guidance Agenda Sees Focus on Generics
Regulatory and Standard Setting Organizations Directory
Regulatory and Standard Setting Organizations Directory
Resources, Guidelines, and Guidance Documents Directory
Resources, Guidelines, and Guidance Documents Directory
Recent Videos
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

EMA Proposes Ways to Improve Development and Evaluation of Biosimilars

Feliza Mirasol
April 8th 2025
Article

The EMA has issued a new proposal that aims to encourage biosimilar development and improve patient access to biosimilar therapies.

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Feliza Mirasol
September 27th 2024
Podcast

This podcast explores the challenges of and the progress made so far by the biopharma industry toward alternative drug delivering methods for biologic drugs.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Sai Life Sciences Establishes Peptide Research Center at R&D Campus in India

Feliza Mirasol
April 7th 2025
Article

Rising demand for peptide-based therapeutics prompts the launch of this new peptide research center, which will offer services across peptide synthesis, discovery, and advanced modalities.

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Felicity Thomas
May 25th 2023
Podcast

Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

Unidentified microbiologist is place the petri dish and tubes into incubator to incubate the culture of bacteria or fungi growth in appropriate condition, concept of microbial laboratory. | Image Credit: © Sukjai Photo – © Sukjai Photo – Stock.Adobe.com

Evolving Cleanroom Procedures and Sterility Challenges

Feliza Mirasol
April 4th 2025
Article

The shift toward personalized medicines poses new challenges in cleanroom protocols.

INTERPHEX 2025: Critical Role of Walk-In Chambers in Bio/Pharma Development and Manufacturing

INTERPHEX 2025: Critical Role of Walk-In Chambers in Bio/Pharma Development and Manufacturing

Patrick Lavery;Feliza Mirasol
April 3rd 2025
Article

Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, sat down with the PharmTech Group at INTERPHEX 2025 to discuss the design and critical role of walk-in chambers in the bio/pharmaceutical industry.

© 2025 MJH Life Sciences

All rights reserved.